Dariush Ghasemi-Semeskandeh

Dariush Ghasemi-Semeskandeh

Auto-generated profile, based on publicly available information

Dariush Ghasemi-Semeskandeh

Affiliations Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands, Institute for Biomedicine, Eurac Research, Bolzano, Italy, Integrative Data Analysis Unit, Health Data Science Centre, Human Technopole, Milan, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in Kidney International Reports
Verified
Journal Article
Open access
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
EKEva König
Eva König
LFLuisa Foco
Luisa Foco
NDNikola Dordevic
Nikola Dordevic
MGMartin Gögele
Martin Gögele
CPCristian Pattaro
Cristian Pattaro
Genome-wide association studies (GWAS) identified a locus on chromosome 4q21.1, spanning the Family With Sequence Similarity 47 Member E (FAM47E), Starch Binding Domain 1 (STBD1), Coiled-Coil Domain Containing 158 (CCDC158), and Shroom Family Member 3 (SHROOM3) genes, to be associated with kidney function markers. Functional studies implicated SHROOM3 as the effector gene, demonstrating its developmental role to guarantee podocyte barrier integrity. However, the locus has also been associated with other clinical traits, including electrolytes, hematological, cardiovascular, and neurological traits, not all of which can be easily traced to the regulation of kidney function. We therefore conducted a systematic analysis of the whole locus’ genetic profiles (haplotypes) to assess which phenotypic profiles they were associated with. For the 4 genes, we reconstructed haplotypes spanning 71 exonic and intronic variants for 12,834 participants in the Cooperative Health Research in South Tyrol (CHRIS) study based on genotypes imputed on a local whole-exome sequencing (WES) reference panel. Haplotypes were tested for associations with 72 clinical traits, 170 serum metabolites, and 148 plasma protein concentrations, using linear regression models. We identified 11 haplotypes with a population frequency between 2% and 24%. Compared with the most common haplotype, most haplotypes were associated with higher creatinine-based estimated glomerular filtration rate (eGFR) and lower serum magnesium levels. In addition, specific haplotypes were also associated with biologically diverse groups of traits, including albuminuria, blood pressure, red blood cell traits, carnitines, and amino acids. Cluster analysis highlighted the existence of distinct genetic profiles in which individuals with specific haplotypes presented with specific phenotypic and metabolic signatures. The genetic variability of the FAM47E–SHROOM3 locus indicates the existence of population subgroups with distinct biomarker profiles.

23 April 2023 in medRxiv
Verified
Preprint
Open access
PDF file
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
DEDavid Emmert
David Emmert
EKEva König
Eva König
LFLuisa Foco
Luisa Foco
GMGögele Martin
Gögele Martin
CPCristian Pattaro
Cristian Pattaro
Chronic kidney disease (CKD) is a complex disease affecting >10% of the global population, with large between-and within-continent variability reflecting major environmental effects. To identify molecular targets for treatment, genome-wide association study meta-analyses (GWAMAs) of CKD-defining traits have identified hundreds of genetic loci in aggregated populations. However, while GWAMAs estimate the average allelic effect across studies, single population studies may be relevant to unravel specific mechanisms. To assess whether an individual study from a specific population could extend existing knowledge on kidney function genetics, we selected 147 kidney function relevant loci identified by a large GWAMA, assessing their association with the glomerular filtration rate estimated from serum creatinine (eGFRcrea) in the Cooperative Health Research In South Tyrol (CHRIS) study (n=10,146), conducted in an Alpine region where thyroid dysfunction is common. We replicated associations with single nucleotide polymorphisms (SNPs) at 11 loci, showing up-to-5.4 times larger effect sizes than in the corresponding GWAMA, not explainable by minor allele frequency differences. Systematic mediation analysis across 70 quantitative traits identified serum magnesium and the activated partial thromboplastin time as partial mediators of the eGFRcrea associations at SHROOM3 and SLC34A1 , respectively. Given that free triiodothyronine and thyroxine were effect modifiers across all loci, we conducted SNP-by-thyroid stimulating hormone (TSH) interaction analyses, identifying significant interactions at STC1 : SNPs had larger effects on eGFRcrea at higher TSH levels, possibly reflecting stanniocalcin-1 autocrine and paracrine role. Individual population studies can help characterize genetic associations. The interplay between phenotypes at SHROOM3 and SLC34A1 and the role of thyroid function as a genetic effect modifier warrant further investigations.

24 June 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
DEDavid Emmert
David Emmert
EKEva König
Eva König
LFLuisa Foco
Luisa Foco
GMGögele Martin
Gögele Martin
CPCristian Pattaro
Cristian Pattaro
Chronic kidney disease (CKD) is a complex disease affecting >10% of the global population, with large between- and within-continent variability reflecting major environmental determinants. To identify molecular targets for treatment and prevention, genome-wide association study meta-analyses (GWAMAs) of CKD-defining traits have identified hundreds of genetic loci in aggregated population samples. However, while GWAMAs estimate the average allelic effect across studies, single population studies may be relevant to unravel specific mechanisms. To assess whether a study sample from a specific population could extend existing knowledge on kidney function genetics, we selected 147 kidney function relevant loci identified by a large GWAMA, assessing their association with the glomerular filtration rate estimated from serum creatinine (eGFRcrea) in 10,146 participants to the Cooperative Health Research In South Tyrol (CHRIS) study, conducted in an Alpine region where thyroid dysfunction is common. We identified associations with single nucleotide polymorphisms (SNPs) at 11 loci, showing up-to-5.4 times larger effect sizes than in the corresponding GWAMA, not explainable by allele frequency differences. Systematic mediation analysis across 70 quantitative traits identified serum magnesium and the activated partial thromboplastin time as partial mediators of the eGFRcrea associations at SHROOM3 and SLC34A1, respectively. Given that free triiodothyronine and thyroxine acted as effect modifiers across all loci, we conducted SNP-by-thyroid stimulating hormone (TSH) interaction analyses, identifying significant interactions at STC1: SNPs had larger effects on eGFRcrea at higher TSH levels, possibly reflecting stanniocalcin-1 autocrine and paracrine role. Individual population studies can help characterize genetic associations. The interplay between phenotypes at SHROOM3 and SLC34A1 and the role of thyroid function as a genetic effect modifier warrant further investigations.

12 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
LFLuisa Foco
Luisa Foco
RFRyosuke Fujii
Ryosuke Fujii
Johannes RainerJohannes Rainer
Johannes Rainer
MFMohadeseh Feli
Mohadeseh Feli
CPCristian Pattaro
Cristian Pattaro
Summary Genome-wide association studies (GWAS) generated thousands of loci associated with complex traits and diseases. However, to characterize of the pleiotropic, molecular and population genetic bounds of uncovered loci, investigations are conducted, that remain conceptually and practically separated. Also in the best case, such investigations proceed by one locus at a time. To address these limitations, we introduce an efficient and reproducible Snakemake pipeline for executing haplotype-based association analysis on GWAS-identified genetic loci, which is especially helpful in samples enriched with molecular omics data. Haplomics takes as input the genetic coordinates of each locus along with all available clinical and molecular phenotypes, the necessary covariates, and VCF genotype files, to reconstruct haplotypes and test them for associations with the phenotypes. The reconstructed haplotypes, the annotation of included variants, and association results are graphically displayed in an HTML report. We tested Haplomics in population-based study sample encompassing 391 traits, including 72 clinical markers, 171 serum metabolites, 148 plasma protein concentrations, and whole-exome sequencing (WES) imputed genotypes. We estimated WES-based haplotypes at 11 kidney function genetic loci from a GWAS and conducted association analyses throughout, identifying 19 significant associations after multiple testing correction. Haplomics is a scalable, easy-to-use and fast haplotype reconstruction and association pipeline that makes it possible to jointly conduct molecular and population-genetic characterization of multiple GWAS loci in unified analysis framework. Availability and implementation Haplomics is freely available on GitHub at https://github.com/dariushghasemi/haplomics.

24 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
EKEva König
Eva König
LFLuisa Foco
Luisa Foco
NDNikola Dordevic
Nikola Dordevic
GMGögele Martin
Gögele Martin
CPCristian Pattaro
Cristian Pattaro
Genome-wide association studies identified a locus on chromosome 4q21.1, spanning the FAM47E , STBD1 , CCDC158 , and SHROOM3 genes, as associated with kidney function markers. Functional studies implicated SHROOM3 , encoding an actin-binding protein involved in cell shaping, into podocyte barrier damage. Despite the locus was also found associated with electrolytes, hematological and cardiovascular traits, systematic explorations of functional variants across all the genes in the locus are lacking. We reconstructed haplotypes covering the whole locus on 12,834 participants to the Cooperative Health Research in South Tyrol (CHRIS) study, using genotypes imputed on a whole-exome sequencing reference panel of a subsample of 3,422 participants. Haplotypes included 146 exonic and intronic variants over the four genes and were tested for association with 73 serum, urine and anthropometric traits, 172 serum metabolite and 148 plasma protein concentrations using linear regression models. We identified 11 haplotypes with 2% to 24% frequency. Compared to the most common haplotype, most haplotypes were associated with higher levels of the creatinine-based estimated glomerular filtration rate and lower serum magnesium levels. The second most common haplotype (12% frequency) was additionally associated with lower dodecanoyl-, hydroxyvaleryl- and tiglyl-carnitine serum concentrations. A haplotype of 4% frequency was also associated with lower red blood cell count, hemoglobin, and hematocrit levels. A haplotype of 2% frequency was associated with serum glutamine and putrescine concentrations. Cluster analysis revealed distinct groups of traits and of haplotypes. The FAM47E - SHROOM3 locus exhibits haplotype variability that corresponds to marked pleiotropic effects, implicating the existence of population subgroups with distinct biomarker profiles.

19 June 2026 in Clinical Kidney Journal
Verified
Journal Article
Open access
GBGiulia Barbieri
Giulia Barbieri
RFRyosuke Fujii
Ryosuke Fujii
MFMichele Filosi
Michele Filosi
DGDariush Ghasemi-Semeskandeh
Dariush Ghasemi-Semeskandeh
GMGögele Martin
Gögele Martin
EHEssi Hantikainen
Essi Hantikainen
Background: Chronic kidney disease (CKD) is a significant global health concern. While diet is crucial to CKD prevention and management, the interaction between diet and genetic predisposition to CKD is underexplored. We conducted an exploratory investigation of the interplay between a polygenic score (PGS) for kidney function and dietary exposures in relation to glomerular filtration rate estimated based on serum creatinine (eGFRcrea) on 5717 generally healthy adult participants of the Cooperative Health Research In South Tyrol (CHRIS) study. Methods: Dietary intake was assessed using the GA2LEN food frequency questionnaire, from which we derived dietary quality indices including the Mediterranean, Alternative Healthy Eating Index (AHEI) and Dietary Approaches to Stop Hypertension (DASH) diets, and nutrients relevant to kidney function (proteins, potassium and phosphorus). Genetic predisposition to lower kidney function was quantified using a PGS derived from 131 single nucleotide polymorphisms (SNPs) whose risk alleles were associated with lower eGFRcrea and higher blood urea nitrogen. We fitted multivariable generalized additive models incorporating diet-by-PGS interaction terms to model non-linear associations with eGFRcrea. Results: The PGS was linearly associated with eGFRcrea (estimated degrees of freedom, df = 1.00, P < 0.0001), regardless of dietary exposures. All nutrients showed significant linear negative associations with eGFRcrea, a pattern not observed for dietary indices. Nominally significant non-linear interactions were observed between the PGS and both protein (df = 4.93, P = 0.0298) and phosphorus intake (df = 5.37, P = 0.0283). Conclusions: The association of dietary protein and phosphorus intake with eGFRcrea may vary by genetic predisposition to low eGFRcrea levels, with stronger dietary effects in those with a high genetic predisposition.